Rising Biopharma R&D Demand Fuels High Throughput Process Development Market According to a newly published market research report by 24LifeSciences, global High Throughput Process Development market is valued at USD 406 million in 2026 and is projected to reach USD 909 million by 2034, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period. High-throughput process development (HTPD) represents a paradigm shift in bioprocessing, integrating miniaturization, automation, and parallelization to create a systematic and highly efficient approach for chromatography and purification process development. This methodology is crucial for accelerating the optimization of biopharmaceutical manufacturing processes, significantly reducing both development time and resource consumption while ensuring robust and scalable production. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9280/high-throughput-process-development-market

Large Volume Wearable Injectors Market Growth Analysis: Opportunities & Forecasts According to a newly published market research report by 24LifeSciences, global large volume wearable injectors market is valued at USD 1.83 billion in 2026 and is projected to reach USD 15.17 billion by 2034, growing at a compound annual growth rate (CAGR) of 36.2% during the forecast period. Large volume wearable injectors (LVPIs), sometimes referred to as bolus injectors or on-body delivery systems, are advanced medical devices engineered to administer subcutaneous injections of high-volume drug formulations, typically exceeding 2 ml. These systems are designed to be discreet, portable, and patient-friendly, allowing for the self-administration of complex biologics and other therapies over extended periods, from several minutes to hours, outside of a clinical environment. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7264/large-volume-wearable-injectors-market

Global Intelligent Hospital Beds Market Size, Growth Drivers & Insights to 2034 According to a newly published market research report by 24LifeSciences, global intelligent hospital beds market is valued at USD 2.54 billion in 2026 and is projected to reach USD 4.92 billion by 2034, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period. Intelligent hospital beds, a cornerstone of modern healthcare infrastructure, represent a significant evolution from traditional medical beds by integrating advanced technologies within the Internet of Medical Things (IoMT) ecosystem. These smart beds are equipped with sensors that continuously monitor critical patient vital signs including respiration, pulse, and body temperature, transmitting real-time data to central monitoring stations and electronic health records. This capability enables healthcare professionals to perform remote patient monitoring and respond proactively to changes in patient conditions, enhancing both safety and clinical outcomes while addressing staffing efficiency challenges. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10475/intelligent-hospital-beds-market